Hear insights from Rajesh T. Gandhi, MD, on some of the most important COVID-19 data reported at the virtual IDWeek 2020 conference, including new findings on transmission in different settings, symptom progression and clinical outcomes, detection of non-SARS-CoV-2 viruses during the pandemic, and treatment and prevention strategies.
In this downloadable slideset, CCO’s expert faculty summarize key COVID-19 studies from this important conference, including new data on transmission in different settings, symptom progression and clinical outcomes, detection of non-SARS-CoV-2 viruses during the COVID-19 pandemic, and treatment and prevention strategies.
Join me on a review of 5 impactful studies on the use of long-acting cabotegravir plus rilpivirine presented at the IDWeek 2020 virtual conference and how I believe these data will impact clinical practice.
Learn about new data presented at the IDWeek 2020 virtual conference on the use of bictegravir/emtricitabine/tenofovir alafenamide in individuals with HIV and end-stage renal disease on hemodialysis.
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.